The pharmacological management of chronic obstructive pulmonary disease involves a stepwise approach
- PDF / 127,097 Bytes
- 4 Pages / 667 x 914 pts Page_size
- 100 Downloads / 204 Views
10.
11.
12.
13.
agonist in a low dose regimen. Acta Obstet Gynecol Scand 1999; 78: 891-9 Graham CA, Sherwin BB. A prospective treatment study of premenstrual symptoms using a triphasic oral contraceptive. J Psychosom Res 1992; 36: 257-66 Bancroft J, Rennie D. The impact of oral contraceptives on the experience of perimenstrual mood, clumsiness, food craving and other symptoms. J Psychosom Res 1993; 37: 195-202 Freeman EW, Kroll R, Rapkin A, et al. Evaluation of a unique oral contraceptive in the treatment of premenstrual dysphoric disorder. J Womens Health Gend Based Med 2001; 10: 564-9 Cullberg J. Mood changes and menstrual symptoms with different gestagen/estrogen combinations: a double-blind comparison with placebo. Acta Psychiatr Scand Suppl 1972; 236: 1-84
14. Walker A, Bancroft J. Relationship between premenstrual symptoms and oral contraceptive use: a controlled study. Psychosom Med 1990; 52: 86-96 15. Dalton K. The premenstrual syndrome and progesterone therapy. London: William Heineman, 1984 16. O’Brien PMS, Craven D, Selby C, et al. Treatment of premenstrual syndrome by spironolactone. Br J Obstet Gynecol 1979; 86: 142-7 17. Casper RF, Hearn MT. The effect of hysterectomy and bilateral oophorectomy in women with severe premenstrual syndrome. Am J Obstet Gynecol 1990; 162: 105-9 18. Bäckström CT, Boyle H, Baird DT. Persistence of symptoms of premenstrual tension in hysterectomized women. Br J Obstet Gynaecol 1981; 88: 530-6
The pharmacological management of chronic obstructive pulmonary disease involves a stepwise approach Chronic obstructive pulmonary disease (COPD) is a slow, progressive deterioration of lung function that is primarily exacerbated by cigarette smoking. As with other respiratory disorders, COPD is treated in a stepwise manner depending on symptom severity as measured using spirometry and other lung function tests. Upon diagnosis of the disease, patients are advised to stop smoking and drug therapy is implemented. Bronchodilators (including β2-agonists, anticholinergics and theophylline) are the first line of treatment of COPD, and clinical studies suggest that particular agents can improve lung function, exercise scores and quality of life. Therapy with more than one concurrent bronchodilator has demonstrated additional benefits. Only patients who have responded to a formal corticosteroid trial should receive long-term inhaled corticosteroids. Long-term oxygen therapy and pulmonary rehabilitation may benefit certain patients.
Every cigarette is doing you damage A progressive disease of the respiratory system, chronic obstructive pulmonary disease (COPD) is characterised by a chronic airflow limitation, and is associated with severe bronchitis and/or emphysema. Cigarette smoking is the major risk factor for developing COPD. The disease affects more than 52 million people worldwide (mostly lower socioeconomic groups),[1] approximately 5% of whom are nonsmokers.[2] In general, 15–25% of heavy smokers develop severe, disabling COPD, although the development of the disease may also be l
Data Loading...
